[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69819515D1 - Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion - Google Patents

Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion

Info

Publication number
DE69819515D1
DE69819515D1 DE69819515T DE69819515T DE69819515D1 DE 69819515 D1 DE69819515 D1 DE 69819515D1 DE 69819515 T DE69819515 T DE 69819515T DE 69819515 T DE69819515 T DE 69819515T DE 69819515 D1 DE69819515 D1 DE 69819515D1
Authority
DE
Germany
Prior art keywords
prostagland
hydroxy
derivatives
erectile dysfunction
treating erectile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69819515T
Other languages
English (en)
Other versions
DE69819515T2 (de
Inventor
Johan Stjernschantz
Bahram Resul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphora AB
Original Assignee
Synphora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora AB filed Critical Synphora AB
Application granted granted Critical
Publication of DE69819515D1 publication Critical patent/DE69819515D1/de
Publication of DE69819515T2 publication Critical patent/DE69819515T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69819515T 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion Expired - Fee Related DE69819515T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702681 1997-07-10
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence
PCT/SE1998/001367 WO1999002164A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69819515D1 true DE69819515D1 (de) 2003-12-11
DE69819515T2 DE69819515T2 (de) 2004-09-23

Family

ID=20407719

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819515T Expired - Fee Related DE69819515T2 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion

Country Status (8)

Country Link
US (1) US6476074B1 (de)
EP (1) EP1003520B1 (de)
JP (1) JP2001509485A (de)
AU (1) AU752049B2 (de)
CA (1) CA2295721A1 (de)
DE (1) DE69819515T2 (de)
SE (1) SE9702681D0 (de)
WO (1) WO1999002164A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
EP1226825A4 (de) 1999-10-07 2004-08-11 Ono Pharmaceutical Co Heilmittel für die erektile dysfunktion
IL139941A0 (en) * 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
CA2416709A1 (en) * 2000-07-31 2003-01-17 Ono Pharmaceutical Co., Ltd. Therapeutic agent for erectile dysfunction containing as the active ingredient prostaglandin derivatives
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
KR100702368B1 (ko) * 2001-07-16 2007-04-02 에프. 호프만-라 로슈 아게 프로스타노이드 작용제로서의 2 피롤리돈 유도체
KR20070087078A (ko) 2001-07-23 2007-08-27 오노 야꾸힝 고교 가부시키가이샤 Ep4 아고니스트를 유효 성분으로 하는 골량 저하 질환의치료제
EP1513589B1 (de) * 2002-06-06 2010-11-10 Merck Frosst Canada Ltd. 1,5-disubstituierte pyrrolid-2-on-derivate zur verwendung als ep4 rezeptor agonisten zur behandlung von augenkrankheiten wie z.b. glaukom
DK2465537T3 (en) 2002-10-10 2016-09-19 Ono Pharmaceutical Co MICROSPHERE INCLUDING ONO-1301
ATE394372T1 (de) 2003-03-03 2008-05-15 Serono Lab G-lactamderivate als prostaglandinagonisten
US7465755B2 (en) 2003-07-18 2008-12-16 Laboratoires Serono Sa Hydrazide derivatives as prostaglandin receptors modulators
ATE455760T1 (de) 2004-12-06 2010-02-15 Merck Serono Sa Pyrrolidin-2-on-derivate zur verwendung als dp1- rezeptoragonisten
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
WO2007115020A2 (en) * 2006-04-04 2007-10-11 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US20150272874A1 (en) 2012-10-29 2015-10-01 Cardio Incorporated Pulmonary disease-specific therapeutic agent
US9968716B2 (en) 2013-10-15 2018-05-15 Ono Pharmaceutical Co., Ltd. Drug-eluting stent graft
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
SE9702681D0 (sv) 1997-07-10
WO1999002164A1 (en) 1999-01-21
EP1003520B1 (de) 2003-11-05
US6476074B1 (en) 2002-11-05
JP2001509485A (ja) 2001-07-24
AU752049B2 (en) 2002-09-05
AU8368298A (en) 1999-02-08
CA2295721A1 (en) 1999-01-21
EP1003520A1 (de) 2000-05-31
DE69819515T2 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
DE69819515D1 (de) Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
FI972205A (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
IL141553A0 (en) Drug preparations for treating sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
EP1027054A4 (de) Lokale anwendung von phosphodiesterase inhibitoren zur behandlung der erektilen dysfunktion
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
HUP0103346A3 (en) Composition and method for treating penile erectile dysfunction
NO20000085D0 (no) Forbedrede metoder og sammensetninger for behandling av erektil dysfunksjon hos menn
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20003065D0 (no) Kombinasjon for effektiv behandling av impotens
NO995823L (no) Terapeutisk middel for ereksjonsdysfunksjon
ID27191A (id) Metode untuk pengobatan insomnia
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
DE69833430D1 (de) Vorrichtung zur abwasserbehandlung
DK0934280T3 (da) PDE-IV-inhiberende 2-cyaniminoimidazolderivater
NO990805D0 (no) Remedium for ereksjonssvikt omfattende kondenserte pyridazinforbindelser
NO20000969D0 (no) Ftalazinderivater og midler for erektil dysfunksjon
EP1161255A4 (de) Verfahren und mittel zur behandlung erektiler dysfunktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee